Ranibizumab for treating choroidal neovascularisation associated with pathological myopia

Technology appraisal guidance
Reference number: TA298
Published: 27 November 2013
Last updated: 20 May 2024

Evidence

Supporting evidence

Review decision
Review decision – October 2016
Review decision paper – October 2016 (PDF 88 KB)

Published:

26 October 2016